Review




Structured Review

Novartis intravitreal injection
Intravitreal Injection, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intravitreal+injection/injection+intravitreal/fda_document____drugsatfda_docs_slash_nda_slash_2019_slash_761125orig1s000admincorres-17-10-0
Average 86 stars, based on 1 article reviews
intravitreal injection - by Bioz Stars, 2026-11
86/100 stars

Images

Related Articles

Injection:

Article Title:
Article Snippet: Regulatory Affairs, CMC Nancy Landzert Andrew Craddock Franchise Head, Regulatory, CMC Biologics Technical Project Leader Arthur Ciociola VP, Franchise Head, Regulatory Affairs Vera Berchten Global Program Regulatory Director Franklin Akomeah Senior Global Program Regulatory Manager Dhaval Desai Julie Clark VP, Medical Unit Head, Ophthalmology Medical Director, US CDMA .. Novartis Pharmaceuticals Corp. (the Sponsor) has developed Brolucizumab solution for intravitreal injection for the treatment of neovascular age-related macular degeneration (nAMD) and plans to submit a BLA in December 2018. ..

Article Title: Pain control and subconjunctival haemorrhage after intravitreal injection using cooled anaesthetic eyedrops and antiseptics: A prospective, double-blind, randomized controlled trial.
Article Snippet: Anti-vascular growth factor (anti-VEGF) intravitreal injections (IVI) are the mainstay of treatment modality in the management of various ophthalmic diseases.. These include exudative age-related macular degeneration (AMD), diabetic macular oedema (DME), proliferative diabetic retinopathy (PDR) and retinal vascular occlusions (RVO) (Peyman et al., 2009).. Relatively low rates of serious associated adverse events (e.g. endophthalmitis (0.019%–0.07%), retinal tears and detachments (0.01%–0.08%)) are reported in the literature (Sampat & Garg, 2010).

Article Title: A rare case of very late recurrence of CSCR-induced CNVM following intra-articular injection of depot steroid
Article Snippet: .. His RE was again treated with intravitreal injection (Accentrix; Novartis India Limited, Mumbai, India) for the recurrent CNVM. .. He gave a history of intra-articular steroid injections (Depo-Medrol; Pfizer Inc., New York, NY, USA) in both knee joints for patellar chondromalacia 6 weeks before the onset of visual symptoms.

Article Title: Vascular endothelial growth factor and its inhibitor in age-related macular degeneration
Article Snippet: .. lable at ScienceDirect Contents lists avai Taiwan Journal of Ophthalmology journal homepage: www.e-t jo.com Review article Vascular endothelial growth factor and its inhibitor in age-related macular degeneration Xiying Wang a,b, Masahito Ohji a,* aDepartment of Ophthalmology, Shiga University of Medical Science, Shiga, Japan bKey Laboratory of Harbin Medical University Eye Center, Eye Hospital, First Affiliated Hospital, Harbin Medical University, Harbin, People’s Republic of China a r t i c l e i n f o Article history: Received 25 August 2013 Received in revised form 9 September 2013 Accepted 11 September 2013 Available online 21 October 2013 Keywords: age-related macular degeneration intravitreal injection vascular endothelial growth factor This article is non-financially supported by Novartis * Corresponding author. ..



Similar Products

94
MedChemExpress intravitreal injections
Intravitreal Injections, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intravitreal+injection/BC1618/pm42501864-125-5-9
Average 94 stars, based on 1 article reviews
intravitreal injections - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

99
MedChemExpress intravitreal injection
Intravitreal Injection, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intravitreal+injection/OF-1/pm42149122-63-14-25
Average 99 stars, based on 1 article reviews
intravitreal injection - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

86
Servicebio Inc intravitreal injection
Intravitreal Injection, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intravitreal+injection/injection+intravitreal/pm41897536-62-19-12
Average 86 stars, based on 1 article reviews
intravitreal injection - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

94
MedChemExpress intravitreous injections
Intravitreous Injections, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intravitreal+injection/Cucurbitacin+I/pmc11974639-104-10-19
Average 94 stars, based on 1 article reviews
intravitreous injections - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

86
System Biosciences Inc rat ad msc ev39 dr ultracentrifugation stz induced sd rats intravitreal injection significant decrease
Rat Ad Msc Ev39 Dr Ultracentrifugation Stz Induced Sd Rats Intravitreal Injection Significant Decrease, supplied by System Biosciences Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intravitreal+injection/ad+decrease+dr+ev39+induced+injection+intravitreal+msc+rat+rats+sd+significant+stz+ultracentrifugation/pm41193438-73-16-14
Average 86 stars, based on 1 article reviews
rat ad msc ev39 dr ultracentrifugation stz induced sd rats intravitreal injection significant decrease - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Intas Pharmaceuticals intravitreal ranibizumab injections
Best corrected visual acuity (ETDRS Letters) Over Time in Innovator <t>ranibizumab</t> vs Biosimilar ranibizumab(Razumab) Groups.
Intravitreal Ranibizumab Injections, supplied by Intas Pharmaceuticals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intravitreal+injection/ranibizumab/pmc12520007-36-13-32
Average 86 stars, based on 1 article reviews
intravitreal ranibizumab injections - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Tenaya Therapeutics intravitreal faricimab ivf injection
Best corrected visual acuity (ETDRS Letters) Over Time in Innovator <t>ranibizumab</t> vs Biosimilar ranibizumab(Razumab) Groups.
Intravitreal Faricimab Ivf Injection, supplied by Tenaya Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intravitreal+injection/faricimab/pm40998549-44-11-4
Average 86 stars, based on 1 article reviews
intravitreal faricimab ivf injection - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Novartis intravitreal injection
Best corrected visual acuity (ETDRS Letters) Over Time in Innovator <t>ranibizumab</t> vs Biosimilar ranibizumab(Razumab) Groups.
Intravitreal Injection, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intravitreal+injection/injection+intravitreal/fda_document____drugsatfda_docs_slash_nda_slash_2019_slash_761125orig1s000admincorres-17-10-0
Average 86 stars, based on 1 article reviews
intravitreal injection - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


Best corrected visual acuity (ETDRS Letters) Over Time in Innovator ranibizumab vs Biosimilar ranibizumab(Razumab) Groups.

Journal: Clinical Ophthalmology (Auckland, N.Z.)

Article Title: Biosimilar Versus Innovator Ranibizumab in Myopic CNVM: Comparative Real-World Outcomes- The BRIM Study

doi: 10.2147/OPTH.S549744

Figure Lengend Snippet: Best corrected visual acuity (ETDRS Letters) Over Time in Innovator ranibizumab vs Biosimilar ranibizumab(Razumab) Groups.

Article Snippet: The study included patients diagnosed with myopic choroidal neovascular membrane (CNVM) who received intravitreal ranibizumab injections—either the innovator molecule (Lucentis/Accentrix ® , Novartis, Mumbai, India) or a biosimilar formulation (Razumab ® , Intas Pharmaceuticals Gujarat, India)—as part of their routine clinical care.

Techniques:

Central macular thickness Comparison Over Time: Innovator ranibizumab vs Biosimilar Ranibizumab (Razumab).

Journal: Clinical Ophthalmology (Auckland, N.Z.)

Article Title: Biosimilar Versus Innovator Ranibizumab in Myopic CNVM: Comparative Real-World Outcomes- The BRIM Study

doi: 10.2147/OPTH.S549744

Figure Lengend Snippet: Central macular thickness Comparison Over Time: Innovator ranibizumab vs Biosimilar Ranibizumab (Razumab).

Article Snippet: The study included patients diagnosed with myopic choroidal neovascular membrane (CNVM) who received intravitreal ranibizumab injections—either the innovator molecule (Lucentis/Accentrix ® , Novartis, Mumbai, India) or a biosimilar formulation (Razumab ® , Intas Pharmaceuticals Gujarat, India)—as part of their routine clinical care.

Techniques: Comparison